INTRODUCTION {#sec1-1}
============

Wounds are major concerns for the patient and clinician alike. Healing of wounds is one of the important areas of clinical medicines explained in many *Ayurvedic* texts under the heading *Vranaropaka*. The wound as a medical problem was first discussed by *Maharshi Agnivesha* in *Agnivesha Samhita* (later known as *Charaka Samhita*) as *Vrana*. *Maharshi Sushruta* in *Sushruta Samhita* elaborated more on wound and its healing. According to the *Ayurveda*, *Vrana* is the discontinuation of the lining membrane, which, after healing, leaves a scar for life closely resembling the modern definition. Similarly, inflammation is considered to be an early phase in the pathogenesis of wounds termed *Vranashotha*. Different types of wounds as mentioned in *Ayurveda*, may be either endogenous in origin due to a defect in human functional units, such as *Vata*, *Pitta* and *Kapha*, or exogenous due to trauma, such as *Chhinna* (cut wound), *Bhinna* (perforated wound), *Viddha* (punctured wound), *Kshata* (lacerated wound), *Picchita* (contusion) and *Ghrista* (abrasion wound).\[[@ref1]\]

*Laghupanchmula* is a group of five small plants' (herbs or undershrubs) roots. Two different classical combinations of *Laghupanchmula* have been advocated each containing roots of four common plants, *Kantakari* (*Solanum surratense* Burm f.), *Brihati* (*Solanum indicum* Linn.), *Shalaparni* (*Desmodium gangeticum* DC.) and *Prinshniparni* (*Uraria picta* Desv.). The fifth plant is eithe *Gokshura* (*Tribulus terrestris* Linn.) as advocated in *Charaka Samhita*\[[@ref2]\], "*Chakradatta*,"\[[@ref3]\] *Shargadhara Samhita*, *Vangasena Samhita*, *Yogaratnakara* and *Bhaisajyasatnavali* (LPG, the first compound formulation) or roots of *Eranda* (*Ricinus communis* Linn.) as advocated in *Sushruta Samhita*,\[[@ref4]\] *Kashyapa Samhita*\[[@ref5]\] and *Siddhasara Samhita*\[[@ref6]\] (LPE, the second compound formulation). The plants included under *Laghupanchamula* have been explored individually for various pharmacological properties. *Solanum surratense* Burm f. juice mixed with whey, chiretta and ginger has been reported to be useful in fever. The juice of leaves, mixed with black pepper, has been prescribed in rheumatism.\[[@ref7]\] *Solanum indicum* Linn. root has been reported to have hepatoprotective, anti-inflammatory and wound healing activities.\[[@ref8][@ref9]\] *Desmodium gangeticum* roots have been documented for therapeutic value in treating typhoid, piles, inflammation, asthma, bronchitis and dysentery.\[[@ref10]\] *Uraria picta* Desv. root has been reported for its analgesic, anti-inflammatory, antioxidant, aphrodisiacs and fracture-healing properties.\[[@ref11]\] *Tribulus terrestris* Linn. has been reported in folk medicine as tonic, aphrodisiac, analgesic, astringent, stomachic, anti-hypertensive, diuretic and urinary anti-infective.\[[@ref12]\] *Ricinus communis* Linn seeds, seed oil, leaves and root have been reported for the treatment of inflammation and liver disorders.\[[@ref13]\] However, wound healing activity of the above two formulations of *Laghupanchmula*, i.e. LPG and LPE, has not been explored earlier. Therefore, a comparative evaluation of 50% ethanolic extract of LPG (LPGE) and LPE (LPEE) for their wound healing (incision and excision wound models) activity in rats and *in vitro* antimicrobial activity on common skin bacteria was evaluated.

MATERIALS AND METHODS {#sec1-2}
=====================

Animals {#sec2-1}
-------

Charles--Foster strain albino rats (150--200 g) and Swiss albino mice (20--30 g) of either sex (*n* = 6) were obtained from the Central Animal House of the Institute, Banaras Hindu University, Varanasi. They were kept in the departmental animal house at 24 ± 2°C and relative humidity 44--56%, light and dark cycles of 10 and 14 h, respectively, for 1 week before and during the experiments. Animals were provided with a standard rodent pellet diet. Principles of laboratory animal care (NIH publication no. 82--23, revised 1985) guidelines were followed. Ethical permission for the investigation of animals used in experiments was taken from the Animal Ethics Committee of the Institute (Notification No. Dean/2012-13/CAEC/214 dated 29.09.2012).

Collection of plant materials {#sec2-2}
-----------------------------

Roots of *Kantakari*, *Brihati*, *Shalaparni*, *Prinshniparni*, *Eranda* or *Gokshura* whole plant were collected from the Rajiv Gandhi South Campus, Banaras Hindu University, Mirzapur in the months of November to December 2009 and a sample specimen of each preserved in the Department of Dravyaguna, IMS, BHU, Varanasi.

Preparation of plant extracts {#sec2-3}
-----------------------------

The collected roots of the above-mentioned plants were shade dried and reduced to a coarse powder using a mechanical grinder and stored in air-dried containers. Two hundred grams each of the dried powder of the roots of *Kantakari*, *Brihati*, *Shalaparni* and *Prinshniparni*, plus either *Gokshura* i.e. LPG (first formulation) or *Eranda* i.e. LPE (second formulation), were taken. Extracts of the above-mentioned two formulations of *Laghupanchamula* (1 kg each) named as LPGE and LPEE were prepared separately in a soxhlet apparatus using 50% ethanol following the standard procedures. The percentage yields of LPGE and LPEE were 10.92% and 10.78%, respectively.

Drugs and chemicals {#sec2-4}
-------------------

Vitamin E was obtained from Merck Ltd., Mumbai, India and all the other chemicals and reagents used were of analytical grade.

Dose selection and treatment protocol {#sec2-5}
-------------------------------------

A preliminary dose--response effect using LPEE and LPGE was first undertaken to study the wound breaking strength (WBS) in incision wound models in rats. Graded doses of LPEE and LPGE 500, 1000 and 1500 mg/kg were administered once daily orally for 10 days in rats following induction of incision wound. The above doses were selected on the basis of our previous reported anti-inflammatory studies with LPEE and LPGE.\[[@ref14]\] The sutures were removed on the 7^th^ day of the experiment and WBS was measured on the 10^th^ post-wounding day. The result of the dose--response study in the incision wound model indicated that 1000 mg/kg of LPEE and LPGE had an optimal effect \[[Table 1](#T1){ref-type="table"}\]. Therefore, the dose of 1000 mg/kg of LPEE and LPGE was chosen for their further study on healing effects on the excision wound model.

###### 

Effect of LPGE, LPEE and Vitamin E on wound breaking strength

![](JAIM-6-241-g001)

LPEE, LPGE (1000 mg/kg) and the standard drug Vitamin E (VTE; 200 mg/kg) suspended in 0.5% carboxy methyl cellulose (CMC) in distilled water were given orally once daily from Day 1, 4 h after the induction of the excision wound. The animals received the extract/VTE orally with the help of an oro-gastric tube in the volume of 1 mL/100 g body weight. For excision wound study, drugs were given for 22 days or earlier till complete healing day, while control rats received 0.5% CMC during the study period.

Wound healing studies {#sec2-6}
---------------------

### Incision wound model {#sec3-1}

Two parallel 6 cm paravertebral incisions were made through the full-thickness of the skin, 1 cm lateral to the midline of the vertebral column after giving anesthesia (Ketamine hydrochloride, 50 mg/kg). Wounds were closed with interrupted sutures, 1 cm apart, with a surgical suture. The sutures were removed on the 7^th^ post-wounding day. WBS was measured on the 10^th^ post-wounding day in anesthetized rats. A line was drawn on either side of the incision line 3 mm away from the wound. Two Allis forceps were firmly applied on to the line facing each other. One of the forceps was fixed, while the other was connected to a freely suspended lightweight polypropylene graduated container through a string run over to a pulley. Standard weights were put slowly and steadily into the container. A gradual increase in weight was transmitted to the wound site pulling apart the wound edges. As and when the wound just opened up, the weight was stopped and noted.\[[@ref15]\]

### Excision wound model {#sec3-2}

Rats were anesthetized with ketamine, an area of about ≈500 mm^2^ was marked on the back of the rat by a standard ring and then the full thickness of the marked skin was cut carefully. Wounds were traced on a 1 mm^2^ graph paper on the day of wounding and subsequently at a gap period of 4 days till the 12^th^ day, then on the alternate days until healing was complete. Changes in wound area were measured regularly and the rate of wound contraction was calculated as given in the formula below. Significance in wound healing of the test groups are derived by comparing the healed wound area on respective days with the healed wound area of the control group. The period of epithelization, i.e. day of fall of eschar, and the scar area were also noted down.\[[@ref16]\]

\% wound contraction = healed area/total wound area × 100

Where, healed area = original wound area - present wound area.

Antimicrobial susceptibility and minimum inhibitory concentration {#sec2-7}
-----------------------------------------------------------------

*In vitro* antibacterial susceptibility test of LPGE and LPEE was performed using serial concentrations of 50, 100, 150 and 200 mg/mL following the approved standards of the National Committee for Clinical Laboratory Standards against common skin bacteria *Staphylococcus aureus* (ATCC 25323), *Staphylococcus epidermidis* and *Pseudomonas aeruginosa* obtained from the American Type Culture Collection (ATCC) and clinical strain preserved at the Department of Microbiology, Institute of Medical Sciences, BHU, Varanasi, India following the disk diffusion method,\[[@ref17]\] while the MIC was performed by the microdilution method.\[[@ref18]\]

Limit test study {#sec2-8}
----------------

Adult Swiss albino mice of either sex, weighing between 20 and 25 g, fasted overnight, were used for the toxicity study. A suspension of LPGE and LPEE was administered orally at 5 g/kg stat dose (five-times of the optimal effective dose) to mice. Subsequent to the administration of the extracts, animals were observed closely for the first 3 h, for any manifestation of toxicity, like increased motor activity, salivation, convulsion, coma and death. Subsequently, observations were made at regular intervals for 24 h. The animals were under further investigation up to a period of 2 weeks.\[[@ref19][@ref20]\]

Statistical analysis {#sec2-9}
--------------------

Statistical comparison was performed using either unpaired *t*-test or one-way analysis of variance (ANOVA) for multiple comparisons versus the control group was carried out by Dunnett\'s test. All statistical analyses were performed using SPSS statistical version 16.0 software package (SPSS^®^ Inc. Armonk, New York, USA).

RESULTS {#sec1-3}
=======

Incision wound {#sec2-10}
--------------

Control rats (0.5% CMC) showed WBS as 400.0 ± 11.5 g on the 10^th^ post-wound day. LPGE 500, 1000 and 1500 mg/kg treated rats showed WBS as 422.17 ± 18.96, 563.3 ± 16.3 and 569.8 ± 17.4 g, respectively, while LPEE 500, 1000 and 1500 mg/kg treated rats showed WBS as 440.67 ± 17.08, 528.3 ± 18.5 and 538.8 ± 18.57 g, respectively. Both these extracts showed a significant increase in WBS when compared with the control group, and this was comparable with 200 mg/kg of VTE (WBS as 550.0 ± 16.3 g). After analyzing the results of the above three different doses of LPGE and LPEE on WBS parameter in incision wound model, an optimal effective dose of 1000 mg/kg both for LPGE and LPEE was selected for further studies in the excision wound model in rats \[[Table 1](#T1){ref-type="table"}\].

Excision wound {#sec2-11}
--------------

The rate of wound contraction in the control rats was 24.0%--63.9% from Day 4 to Day 12 and 78.3--98.0% from Day 14 to Day 20, while complete epithelization and healing was observed on Day 22. The average number of days that took for the shedding of eschar without leaving any residual raw wound in these rats was 11.2 days, and the mean of the scar area was 185.7 mm^2^. The percent rate of wound contraction in rats treated with LPGE was from 32.1% on Day 4 to 80.2% on Day 12 and 90.2--100% from Day 14 to Day 20. The percent rate of wound contraction in rats treated with LPEE was from 33.5% on Day 4 to 75.6% on Day 12 and 85.0% to 99.5% from Day 14 to Day 20, while complete wound healing was observed on the 21^st^ day. VTE treated rats showed an increase in wound contraction from 35.4% on Day 4 to 80.3% on Day 12 and 89.2--100% from Day 14 to Day 20. LPGE and LPEE showed a time-dependant healing effect on wound surface area in excision wound model in rats. The area under the curve (AUC) of the LPGE- and LPEE-treated groups versus the control group gave an indication of faster healing, which was comparable with that of the VTE-treated group. The mean epithelization period and scar area observed with LPGE and LPEE were 9.17 days and 88.8 mm^2^ and 8.67 days and 114.7 mm^2^, respectively, while the mean epithelization period and scar area observed with VTE were 8.17 days and 88.3 mm^2^, respectively \[[Table 2](#T2){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}\].

###### 

Effect of LPGE, LPEE and Vitamin E on wound contraction, epithelization period and scar area
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![Photographic representation of contraction rate showing percent wound contraction area on different post-excision days of control, *Laghupanchamula* containing *Gokshura* (LPGE) and *Laghupanchamula* containing *Eranda* (LPEE) (1000 mg/kg) and Vitamin E (VTE) (200 mg/kg) treated rats](JAIM-6-241-g003){#F1}

Histology of excision biopsy of skin wound at day 10 showed healed skin structures with normal epithelization, restoration of adnexa and fibrosis within the dermis in LPGE, LPEE and VTE treated groups while the control group lags behind treated groups in formation of the amount of ground substance in the granulation tissue \[[Figure 2](#F2){ref-type="fig"}\].

![Histopathology of skin tissue at Day 10 stained with hematoxylin and eosin (x20). (a) Skin tissue of carboxy methyl cellulose-treated control rat showed extensive damage with ulcerated epidermis filled with only granulation tissue comprising of mononuclear inflammatory cells (red arrow), collagen tissue (yellow arrow) and blood vessels (blue arrow), (b) Vitamin E (200 mg/kg)-treated rats showed near-normal epidermis with mild to moderate mononuclear infiltrate in the underlying dermis and few blood vessels, (c) skin tissue of *Laghupanchamula* containing *Gokshura* (1000 mg/kg)-treated rat showed mild mononuclear inflammatory cells (red arrow), abundant collagen tissue (yellow arrow) and few blood vessels (blue arrow) and (d) *Laghupanchamula* containing *Eranda* (1000 mg/kg)-treated rat shows moderate amount of mononuclear infiltrate interspersed with thin-walled blood vessels](JAIM-6-241-g004){#F2}

Antimicrobial susceptibility and MIC {#sec2-12}
------------------------------------

The LPGE and LPEE extracts showed a positive susceptibility test against the common skin bacteria *Staphylococcus aureus* (ATCC 25323), *Staphylococcus epidermidis* and *Pseudomonas aeruginosa*, showing a zone of inhibition ≥10 mm at 200 mg/mL. LPEE had the lowest MIC of 1.57 mg/mL against *Staphylococcus aureus* (ATCC 25323) and 3.13 mg/mL against *Pseudomonas aeruginosa*, whereas the MIC of LPGE and LPEE against other organisms ranged from 6.25 to 25.0 mg/mL \[[Table 3](#T3){ref-type="table"}\].

###### 

Antibacterial activity and minimum inhibitory concentration of LPGE and LPEE
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Limit test study {#sec2-13}
----------------

LPGE and LPEE, even at five-times their optimal effective doses, i.e. 5 g/kg, when given in stat dose, orally, did not show any acute toxic manifestations like increased motor activity, compulsive behavior, salivation, convulsions, coma or death when observed up to a period of 2 weeks.

DISCUSSION {#sec1-4}
==========

The plants included under *Laghupanchamula* have been explored individually for various pharmacological properties, but no such comparative study was performed earlier with the two formulations of *Laghupanchamula* that were advocated in the *Ayurvedic* compendia for various inflammatory ailments. Presently, a comparative study was performed with the two formulations of LP on their wound healing activity using incision and excision wound models in rats and also *in vitro* antimicrobial activity against some common skin microorganisms.

Wound healing consists of an orderly progression of events that re-establish the integrity of the damaged tissue: Inflammatory, proliferation and remodeling stages.\[[@ref21]\] The inflammation stage begins immediately after injury, first with vaso-constriction that favors homeostasis and releases inflammation mediators. The proliferative phase is characterized by granulation tissue proliferation formed mainly by fibroblast and the angiogenesis process. The remodeling stage is characterized by reformulations and improvement in the components of the collagen fibers that increases the tensile strength.\[[@ref22]\] Thus, it is generally believed that alterations in the first phase, which is the inflammatory one, will impact the overall integrity of the healing wound.\[[@ref23]\] The involvement of each phase has been reported to vary over a spectrum dependent largely on the type, location and milieu factors influencing the wound. The healing process thus depends, to a large extent, on the regulated biosynthesis and deposition of new collagens and their subsequent maturation.\[[@ref15]\] In our present incision wound study, both the extracts showed increased WBS as compared with the control. In this model, the increase in tensile strength of the treated wounds may be due to the increase in collagen concentration and stabilization of the fibers.\[[@ref24]\] It may be postulated that the collagen molecules synthesized at the wound site are laid down and become cross-linked to form fibers. Wound strength is thus acquired from both remodeling of collagen and the formation of stable intra- and inter-molecular cross-links. Because incision wounds treated with LPGE and LPEE showed greater breaking strength, it may increase remodeling of collagen and the formation of stable intra- and inter-molecular cross-links.\[[@ref25]\]

Epithelization is the process where keratinocytes migrate from the lower skin layers and divide. Contraction is the process where the wound contracts, narrows or closes the wound. The movement of fibroblast s in the wound area facilitates matrix formation and collagen is laid down over and throughout the amorphous material. In the tissue repair process, inflammatory cells promote the migration and proliferation of endothelial cells, leading to neovascularization of connective tissue cells that synthesize extracellular matrices including collagen and of keratinocytes resulting in re-epithelialization of the wounded tissue.\[[@ref26]\] In the excision wound model, both extracts showed faster healing compared with the control group. The faster wound contraction rate of the extracts may be due to stimulation of interleukin-8, an inflammatory α-chemokine, which affects the function and recruitment of various inflammatory cells, fibroblasts and keratinocytes, and may increase the gap junctional intracellular communication in fibroblasts and induce a more rapid maturation of granulation tissue.\[[@ref27]\] The granulation tissue of the wound is primarily composed of fibroblasts, collagen and small new blood vessels. The undifferentiated mesenchymal cells of the wound margin modulate themselves into fibroblasts, which start migrating into the wound gap along with the fibrin strands. LPGE and LPEE showed a decrease in days of epithelization and scar area due to an increase in granulation tissue.

Wound infections are most common in developing countries because of poor hygienic conditions. *Staphylococcus aureus*, *Streptococcus pyogenes*, *Escherichia coli*, *Pseudomonas aeruginosa*, *Streptococcus pneumonia* and *Klebsiella pneumonia*, etc., are some important microorganisms causing wound infection.\[[@ref28]\] Presence of bacteria on an ulcer may lead to active infection, with subsequent interference in the process of wound healing. The detrimental effect of bacteria on wound healing results from several mechanisms. Bacteria release a variety of endotoxins, which may reduce the proliferative capacity of fibroblasts and epithelial cells. Moreover, bacteria may affect cell function even to the extent of cellular destruction. Secreted toxins may cause lysis of collagen and fibrin as well as the degradation of growth factors. In addition, consumption of nutrients and oxygen by the invading bacteria at the expense of the newly forming tissue leads to tissue anoxia, with further delay in the healing process.\[[@ref29]\] LPGE and LPEE showed antimicrobial activity against *Staphylococcus aureus*, *Staphylococcus epidermidis* and *Pseudomonas aerugenosa*, and lowest MIC was found with LPEE against *Staphylococcus aureus*. Beside promoting collagen deposition, both LPGE and LPEE have antimicrobial properties, which may contribute to their early healing potential.

Phytochemical analysis of plants used in LPGE and LPEE reported the presence of flavonoids, tannins, alkaloids, essential oils and saponins.\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\] Tannins are important compounds known to be potent cyclooxygenase-1 inhibitors and have anti-inflammatory and wound healing properties.\[[@ref30]\] Alkaloids, flavonoids and saponins have also been reported to possess anti-oxidant, anti-radical, wound healing and antimicrobial properties.\[[@ref31][@ref32][@ref33][@ref34]\] The wound healing and antimicrobial effects of the extract may therefore be due to the presence of flavonoids, tannins, alkaloids and saponins. The limit test (acute toxicity) study in mice also revealed the safety profile of the test extracts, LPGE and LPEE.

It could be concluded that 50% ethanolic extract of *Laghupanchamula* formulations containing either *Eranda* or *Gokshura* (LPEE and LPGE) possessed wound healing and antimicrobial activities that could be due to the presence of flavonoids, alkaloids, essential oils, saponins and tannins present in it. Further, we did not find any significant difference in their wound healing activity. Therefore, the use of any of these formulations in the traditional *Ayurvedic* system for the treatment of wound healing is justified.
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